Novel therapeutic approach for Alzheimer's disease by removing amyloid β protein from the brain with an extracorporeal removal system

Journal of Artificial Organs

Volumn 13, Issue 1, 2010, Pages 31-37

  Kawaguchi, Kazunori ^a   Kitaguchi, Nobuya ^a   Nakai, Shigeru ^a   Murakami, Kazutaka ^b   Asakura, Kunihiko ^b   Mutoh, Tatsuro ^b   Fujita, Yoshiro ^c   Sugiyama, Satoshi ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOYOTA MEMORIAL HOSPITAL   (Japan)

Author keywords

Adsorbent; Alzheimer's disease; Amyloid beta; Blood purification; Extracorporeal circulation

Indexed keywords

ADSORBENT; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BLOOD CLOTTING FACTOR; BOVINE SERUM ALBUMIN; CELLULOSE; CELLULOSE ACETATE; CELLULOSE PARTICLE LIGATED WITH DEXTRAN SULFATE; CHARCOAL; HEXADECYL ALKYLATED CELLULOSE; IMMUNOGLOBULIN; NONWOVEN POLYETHYLENE TEREPHTHALATE; PLASMA PROTEIN; POLYETHYLENE TEREPHTHALATE; POLYVINYL ALCOHOL; TRYPTOPHAN LIGATED POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ADSORPTION; ADULT; ARTICLE; CASE REPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPERIMENTAL TEST; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODIALYSIS; HUMAN; METHODOLOGY; PLASMA; PRIORITY JOURNAL;

ADSORPTION; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; EXTRACORPOREAL CIRCULATION; HUMANS;

EID: 77951254201     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-010-0482-3     Document Type: Article

References (22)

1. YM Kuo MR Emmerling C Vigo-Pelfrey TC Kasunic JB Kirkpatrick GH Murdoch MJ Ball AE Roher 1996 Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains J Biol Chem 271 4077 4081 10.1074/jbc.271.8.4077 1:CAS:528:DyaK28XhtlSmsL8%3D 8626743 (Pubitemid 26070502)
2. DJ Selkoe 2001 Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81 741 766 1:CAS:528:DC%2BD3MXislCrsLc%3D 11274343
3. LW Hung GD Ciccotosto E Giannakis DJ Tew K Perez CL Masters R Cappai JD Wade KJ Barnham 2008 Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimers correlate with neurotoxicity J Neurosci 28 46 11950 11958 10.1523/JNEUROSCI.3916-08.2008 1:CAS:528:DC%2BD1cXhsVarurnE 19005060
4. DM Walsh I Klyubin JV Fadeeva WK Cullen R Anwyl MS Wolfe MJ Rowan DJ Selkoe 2002 Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 535 539 10.1038/416535a 1:CAS:528:DC%2BD38XivVOntL8%3D 11932745 (Pubitemid 34288854)
5. D Schenk R Barbour W Dunn G Gordon H Grajeda T Guido K Hu J Huang K Johnson-Wood K Khan D Kholodenko M Lee Z Liao I Lieberburg R Motter L Mutter F Soriano G Shopp N Vasquez C Vandevert S Walker M Wogulis T Yednock D Games P Seubert 1999 Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 173 177 10.1038/22124 1:CAS:528:DyaK1MXks1Khsbc%3D 10408445 (Pubitemid 29327547)
6. J-C Dodart KR Bales KS Gannon SJ Greene RB DeMattos C Mathis CA DeLong S Wu X Wu DM Holtzman SM Paul 2002 Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model Nat Neurosci 5 452 457 1:CAS:528:DC%2BD38XjtFykurY%3D 11941374 (Pubitemid 34454251)
7. C Hock U Konietzko JR Streffer J Tracy A Signorell B Müller- Tillmanns U Lemke K Henke E Moritz E Garcia MA Wollmer D Umbricht DJ de Quervain M Hofmann A Maddalena A Papassotiropoulos RM Nitsch 2003 Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease Neuron 38 547 554 10.1016/S0896-6273(03)00294-0 1:CAS:528:DC%2BD3sXksVOjs7c%3D 12765607 (Pubitemid 36645030)
8. V Geylis M Steinitz 2006 Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Aβ) human monoclonal antibodies Autoimmun Rev 5 33 39 10.1016/j.autrev.2005.06.007 16338209 (Pubitemid 41759440)
9. AJ Bayer R Bullock RW Jones D Wilkinson KR Paterson L Jenkins SB Millais S Donoghue 2005 Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD Neurology 64 94 101 1:CAS:528: DC%2BD2cXhtFeisr7J 15642910 (Pubitemid 40082943)
10. C Holmes D Boche D Wilkinson G Yadegarfar V Hopkins A Bayer RW Jones R Bullock S Love JW Neal E Zotova JA Nicoll 2008 Long-term effects of Aβ 42 immunization in Alzheimer's disease: follow-up of a randomized, placebo-controlled phase I trial Lancet 372 216 223 10.1016/S0140-6736(08)61075- 2 1:CAS:528:DC%2BD1cXoslWkt74%3D 18640458 (Pubitemid 351978111)
11. RC Dodel Y Du C Depboylu H Hampel L Frölich A Haag U Hemmeter S Paulsen SJ Teipel S Brettschneider A Spottke C Nölker HJ Möller X Wei M Farlow N Sommer WH Oertel 2004 Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer's disease J Neurol Neurosurg Psychiatry 75 1472 1474 10.1136/jnnp.2003.033399 1:STN:280:DC%2BD2cvpvFyqsA%3D%3D 15377700 (Pubitemid 39279821)
12. JA Nicoll D Wilkinson C Holmes P Steart H Markham RO Weller 2003 Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report Nat Med 9 448 452 10.1038/nm840 1:CAS:528: DC%2BD3sXisVOmu78%3D 12640446 (Pubitemid 36460079)
13. RB DeMattos KR Bales DJ Cummins JC Dodart SM Paul DM Holtzman 2001 Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc Natl Acad Sci USA 98 8850 8855 10.1073/pnas.151261398 1:CAS:528:DC%2BD3MXls1Wiurk%3D 11438712 (Pubitemid 32678116)
14. RB DeMattos KR Bales DJ Cummins SM Paul DM Holtzman 2002 Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease Science 295 2264 2267 10.1126/science.1067568 1:CAS:528:DC%2BD38XitlGkt7g%3D 11910111 (Pubitemid 34258840)
15. JE Donahue SL Flaherty CE Johanson JA Duncan GD Silverberg MC Miller R Tavares W Yang Q Wu E Sabo V Hovanesian EG Stopa 2006 RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease Acta Neuropathol 112 405 415 10.1007/s00401-006-0115-3 1:CAS:528:DC%2BD28XhtVagsrzN 16865397 (Pubitemid 44469161)
16. RD Bell AP Sagare AE Friedman GS Bedi DM Holtzman R Deane BV Zlokovic 2007 Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system J Cereb Blood Flow Metab 27 909 918 1:CAS:528:DC%2BD2sXlvVSktro%3D 17077814 (Pubitemid 46659038)
17. Y Matsuoka M Saito J LaFrancois M Saito K Gaynor V Olm L Wang E Casey Y Lu C Shiratori C Lemere K Duff 2003 Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to β-amyloid J Neurosci 23 29 33 1:CAS:528:DC%2BD3sXktlajsQ%3D%3D 12514198 (Pubitemid 36050401)
18. J Laurén DA Gimbel HB Nygaard JW Gilbert SM Strittmatter 2009 Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers Nature 457 1128 1132 10.1038/nature07761 19242475
19. K Hasegawa K Ono M Yamada H Naiki 2002 Kinetic modeling and determination of reaction constants of Alzheimer's β-amyloid fibril extension and dissociation using surface plasmon resonance Biochemistry 41 13489 13498 10.1021/bi020369w 1:CAS:528:DC%2BD38XotFGgtbY%3D 12427009 (Pubitemid 35332684)
20. OL Lopez LH Kuller PD Mehta JT Becker HM Gach RA Sweet YF Chang R Tracy ST DeKosky 2008 Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study Neurology 70 1664 1671 10.1212/01.wnl. 0000306696.82017.66 1:CAS:528:DC%2BD1cXnsFGgsbY%3D 18401021 (Pubitemid 351644132)
21. NS Schoonenboom C Mulder GJ Van Kamp SP Mehta P Scheltens MA Blankenstein PD Mehta 2005 Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same? Ann Neurol 58 139 142 10.1002/ana.20508 1:CAS:528: DC%2BD2MXntVWrsLc%3D 15984010 (Pubitemid 40962469)
22. GM Megson DA Stevens JR Hamilton DW Dennig 1996 d-mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis J Clin Microbiol 34 218 221 1:STN:280:DyaK28zltlShtg%3D%3D 8748311 (Pubitemid 3013887)